141 related articles for article (PubMed ID: 17313836)
41. Down-regulation of cytoplasmic PLZF correlates with high tumor grade and tumor aggression in non-small cell lung carcinoma.
Xiao GQ; Li F; Findeis-Hosey J; Hyrien O; Unger PD; Xiao L; Dunne R; Kim ES; Yang Q; McMahon L; Burstein DE
Hum Pathol; 2015 Nov; 46(11):1607-15. PubMed ID: 26297253
[TBL] [Abstract][Full Text] [Related]
42. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
[TBL] [Abstract][Full Text] [Related]
43. Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival.
Laudanski J; Chyczewski L; Niklińska WE; Kretowska M; Furman M; Sawicki B; Nikliński J
Neoplasma; 1999; 46(1):25-30. PubMed ID: 10355530
[TBL] [Abstract][Full Text] [Related]
44. [The expression of P16 and Rb proteins in 106 cases of lung cancer].
Qin J; Chen G; Wang X
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Oct; 23(10):588-90. PubMed ID: 11372380
[TBL] [Abstract][Full Text] [Related]
45. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S
Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641
[TBL] [Abstract][Full Text] [Related]
46. P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens.
Švajdler M; Mezencev R; Ondič O; Šašková B; Mukenšnábl P; Michal M
Ann Diagn Pathol; 2018 Apr; 33():23-29. PubMed ID: 29566943
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma.
Puglisi F; Barbone F; Damante G; Bruckbauer M; Di Lauro V; Beltrami CA; Di Loreto C
Mod Pathol; 1999 Mar; 12(3):318-24. PubMed ID: 10102618
[TBL] [Abstract][Full Text] [Related]
48. [Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer].
Liu HX; Xing LX; Wang HB; Yang JQ; Sun YM
Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):615-9. PubMed ID: 19094586
[TBL] [Abstract][Full Text] [Related]
49. Expression of IRAK1 in lung cancer tissues and its clinicopathological significance: a microarray study.
Zhang X; Dang Y; Li P; Rong M; Chen G
Int J Clin Exp Pathol; 2014; 7(11):8096-104. PubMed ID: 25550857
[TBL] [Abstract][Full Text] [Related]
50. [The molecular mechanism of PML in inducing apoptosis of bladder cancer cell line].
Li L; He DL; He H; Wang XY; Zhang LL; Luo Y; Nan XY
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1766-9. PubMed ID: 16253165
[TBL] [Abstract][Full Text] [Related]
51. Characterization of endogenous human promyelocytic leukemia isoforms.
Condemine W; Takahashi Y; Zhu J; Puvion-Dutilleul F; Guegan S; Janin A; de Thé H
Cancer Res; 2006 Jun; 66(12):6192-8. PubMed ID: 16778193
[TBL] [Abstract][Full Text] [Related]
52. [TTF-1 expression and its diagnostic application in lung carcinomas].
Lin DM; Zou SM; Lü N; Wen P; Liu XY; He ZG
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):615-7. PubMed ID: 15634524
[TBL] [Abstract][Full Text] [Related]
53. Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer.
Zhang H; Melamed J; Wei P; Cox K; Frankel W; Bahnson RR; Robinson N; Pyka R; Liu Y; Zheng P
Cancer Immun; 2003 Feb; 3():2. PubMed ID: 12747744
[TBL] [Abstract][Full Text] [Related]
54. [Expression of PML in carcinogenesis of laryngocarcinoma and nasopharyngeal carcinoma].
Chen W; Yao W; Chen S; Xiao B; Tao Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Feb; 21(3):128-31. PubMed ID: 17441430
[TBL] [Abstract][Full Text] [Related]
55. Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma.
Di Loreto C; Di Lauro V; Puglisi F; Damante G; Fabbro D; Beltrami CA
J Clin Pathol; 1997 Jan; 50(1):30-2. PubMed ID: 9059352
[TBL] [Abstract][Full Text] [Related]
56. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens.
Nicholson SA; Beasley MB; Brambilla E; Hasleton PS; Colby TV; Sheppard MN; Falk R; Travis WD
Am J Surg Pathol; 2002 Sep; 26(9):1184-97. PubMed ID: 12218575
[TBL] [Abstract][Full Text] [Related]
57. Alteration of laminin production in small-cell lung carcinoma: possible correlation with the absence of the basement membrane.
Mastroianni A; Invernizzi L; Tagliabue E; Fassina G; Albini A; Ménard S; Colnaghi MI
Tumour Biol; 1993; 14(5):279-87. PubMed ID: 8235307
[TBL] [Abstract][Full Text] [Related]
58. PML expression in soft tissue sarcoma: prognostic and predictive value in alkylating agents/antracycline-based first line therapy.
Vincenzi B; Santini D; Schiavon G; Frezza AM; Silletta M; Crucitti P; Casali P; Dei Tos AP; Rossi S; Rizzo S; Badalamenti G; Tomasino RM; Russo A; Butrynski JE; Tonini G
J Cell Physiol; 2012 Apr; 227(4):1657-62. PubMed ID: 21678421
[TBL] [Abstract][Full Text] [Related]
59. Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas.
Chang HJ; Yoo BC; Kim SW; Lee BL; Kim WH
Pathol Oncol Res; 2007; 13(4):326-35. PubMed ID: 18158568
[TBL] [Abstract][Full Text] [Related]
60. Expression of epithelial-cell adhesion molecule (Ep-CAM) in small cell lung cancer as defined by monoclonal antibodies 17-1A and BerEP4.
Brezicka T
Acta Oncol; 2005; 44(7):723-7. PubMed ID: 16227163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]